CCNQP1

Across TCGA pan-cancer cohorts, CCNQP1 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated CCNQP1 data layer compared with 14 for mass-spec protein.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher CCNQP1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CCNQP1 expression acts as an unfavorable survival marker.

BLCA, LUAD, and PRAD are the cancer types where CCNQP1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Median	All	0.195	0.720	.003	18	view →
LUAD	OS	Median	III,IV	0.057	0.680	<.001	15	view →
PRAD	DFS	Median	All	0.107	0.886	<.001	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

CCNQP1–BLCA (OS)

Open the BLCA breakdown →